| 标题 |
First‐line envafolimab plus recombinant human‐endostatin in advanced non–small cell lung cancer with PD‐L1 tumor proportion score ≥1% (Endouble): A multicenter, prospective, single‐arm, phase 2 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Cancer 作者:Changhong Dong; Liang Liu; Yun Qiao; Mei Wang; Dan Song; et al 出版日期:2026-05-29 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)